Nutraceuticals: Scaling Without Breaking Supply
Day 3 Supply & Formulation Excellence Stage
08/10/2026 10:30 - 11:15am
Contributors
Marie Quettier : Programming Co-Chair - Women in Nutraceuticals
Amedeo Chiappini : Acting CEO - Hubmed Technologies GmbH
Cynthia Hunefeld : Founder & CEO - Evithé Biotechnology
Steve Jennings : Co-Founder and CEO - Jenerise Ltd.
Paweł Gruszczyński : CEO / Founder - Remedy
Nutraceuticals are growing faster than almost any adjacent health category, but the infrastructure behind them hasn't caught up. Tariff volatility and raw material shortages are exposing single-source dependencies in botanical and specialty ingredient supply. Regulators in the US and EU are simultaneously tightening scrutiny — from GRAS reform and marketing enforcement to new packaging and traceability rules. And consumers are no longer satisfied with wellness claims; they want proof of bioavailability and efficacy.
This panel examines how nutraceutical companies are adopting pharma-grade discipline — supplier qualification, traceability, evidence-based formulation — without losing the speed that defines the category. Topics include diversifying ingredient sourcing under tariff pressure, navigating a fragmenting regulatory landscape, and what "proof" will mean for the next generation of functional health products.